Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Akero Therapeutics Inc
Swot
Akero Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Akero Therapeutics Inc has 15 Strengths, 7 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(7)
Opportunity
(2)
Threats
(1)
Others
(0)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Highest Recovery from 52 Week Low
Promoter decreasing their shareholding
Negative profit growth, promoters decreasing shareholding QoQ
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
MFs decreased their shareholding last quarter